Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue sup3: 2011 Vol. 27, No. S3 CMRO Online Special Issue on Diabetes
Submit an article Journal homepage
252
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus

Kohei KakuDivision of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kawasaki Medical School Okayama, JapanCorrespondence[email protected]
,
Kazuaki EnyaPharmaceutical Development Division, Takeda Pharmaceutical Company Limited Osaka, Japan
,
Kenkichi SugiuraPharmaceutical Development Division, Takeda Pharmaceutical Company Limited Osaka, Japan
&
Nobuo TotsukaPharmaceutical Development Division, Takeda Pharmaceutical Company Limited Osaka, Japan
Pages 73-84 | Accepted 05 Oct 2011, Published online: 23 Nov 2011

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vasilios G. Athyros, Niki Katsiki & Asterios Karagiannis. (2013) Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients. Current Medical Research and Opinion 29:7, pages 791-792.
Read now

Articles from other publishers (3)

Hephzibah Kola & Sangeetha Shanmugasundaram. (2023) Analytical quality by design-based RP-HPLC method for quantification of pioglitazone and candesartan cilexetil in bilayer tablet and its forced degradation studies. Pharmacia 70:1, pages 27-37.
Crossref
. (2012) Current World Literature. Current Opinion in Nephrology & Hypertension 21:5, pages 557-566.
Crossref
. (2012) Current World Literature. Current Opinion in Cardiology 27:4, pages 441-454.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.